JPRN-jRCT2080225290已完成1 期
A Phase I, Open label, Multi-Center Clinical Pharmacological Study of nemolizumab with a Single-dose in Japanese Atopic Dermatitis Patients with moderate to severe pruritus
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 13age old 至 <= 59age old（—）
- 性别
- All
入选标准
- •Atopic dermatitis with moderate or severe pururitus Patients
排除标准
- •-Patients with Hepatitis B virus or hepatitis C virus infection
- •-Patients with Evidence of tuberculosis (TB) infection
- •-Patients with immune deficiency
- •-Pregnant or lactating women
研究者
相似试验
尚未招募
不适用
A phase I, multi-center, open-label, drug-drug interaction study to assess the effect of the CYP1A2 inhibitor, fluvoxamine, on TKI258 (dovitinib) pharmacokinetics in patients with advanced solid tumors.advanced cancersolid tumors10027655NL-OMON39285ovartis12
已完成
不适用
A Phase 1, Open-Label, Multicenter, Drug-Drug Interaction Study of TAK-788 and Midazolam, a Sensitive CYP3A Substrate, in Patients With Advanced Non*Small Cell Lung Cancerlung tumorLung cancerNL-OMON49519Millenium Pharmaceuticals6
进行中（未招募）
1 期
A study to evaluate the safety, processing by the body and response of the body to tenecteplase in adults with acute ischemic strokeISRCTN13376195Roche (United States)20
招募中
4 期
A multicentre study of the dose concentration response of febuxostat in patients with chronic gout.ACTRN12616000959471St Vincent's Hospital120
进行中（未招募）
1 期
A study to evaluate the effect of Levonorgestrel-Emergency Contraception Tablet on Ovulation Inhibition in groups with a BMI that ranges underweight to obeseOvulationMedDRA version: 20.0Level: PTClassification code 10036251Term: Post coital contraceptionSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 20.0Level: LLTClassification code 10033313Term: Ovulation inhibitedSystem Organ Class: 100000004860EUCTR2019-001143-43-GBGedeon Richter Plc.520